Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
Provided By GlobeNewswire
Last update: Jan 27, 2025
- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT® -
Read more at globenewswire.comNASDAQ:DRTSW (11/10/2025, 1:54:19 PM)
0.285
+0 (+1.79%)
3.714
-0.15 (-3.93%)
Find more stocks in the Stock Screener
